Thalidomide 100mg ( DrugBank: Thalidomide )

1 disease

ID	Disease name (Link within this page)	Number of trials
271	Ankylosing spondylitis	2

271. Ankylosing spondylitis

Clinical trials : 574 / Drugs : 359 - (DrugBank : 68) / Drug target genes : 41 - Drug target pathways : 146

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR-TRC-13003449	2013-04-25	2013-06-07	A multicenter, randomized, double-blind, placebo-controlled, Phase II clinical study of Thalidomide ...	A multicenter, randomized, double-blind, placebo-controlled, Phase II clinical study of Thalidomide ...	Ankylosing Spondylitis	Thalidomide 150mg:Thalidomide 25mg/qd.po.2weeks; 50mg/qd.po.2weeks;100mg/qd.po.2weeks; 150mg/qd, po. ...	The General Hospital of People's Liberation Army	NULL	Completed	18	65	Both	Thalidomide 150mg:80;Thalidomide 100mg:80;Control group:40;	2 (Phase 2 study)	China
2	NCT02201043 (ClinicalTrials.gov)	February 2013	23/7/2014	Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis	A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase II Clinical Study of Thalidomide ...	Ankylosing Spondylitis	Drug: Thalidomide 150mg;Drug: Thalidomide 100mg;Drug: Placebo	Shanghai Pharmaceuticals Holding Co., Ltd	NULL	Completed	18 Years	65 Years	Both	197	Phase 2	China

First Previous1Next Last